Editorial: Strategies and barriers for hepatitis B cure: implications for HIV
Curr Opin HIV AIDS
.
2020 May;15(3):151-156.
doi: 10.1097/COH.0000000000000620.
Authors
Peter A Revill
1
,
Sharon R Lewin
Affiliation
1
The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.
PMID:
32229770
DOI:
10.1097/COH.0000000000000620
No abstract available
Publication types
Editorial
MeSH terms
Antiviral Agents / therapeutic use
HIV Infections* / drug therapy
Hepatitis B* / drug therapy
Humans
Substances
Antiviral Agents